AnalystsGeorge FarmerGeorge Farmer's Stock Forecasts
AnalystsGeorge Farmer
Sectors:
Industries:
Analyst Ranking
Top 26%
#1274 out of 4870 analysts
Average Return
+5.12%
Win Rate
32%13 out of 41
Risk vs Reward
Poor
Good
George Farmer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tempest Therapeutics IncTPST | +787.31% | $0.77 | $6.85 | 2025-03-27 - 2025-05-01 | Buy |
Pandion Therapeutics IncPAND | +219.76% | $18.78 | $60.05 | 2020-08-09 - 2021-03-31 | Buy |
Blueprint Medicines CorpBPMC | +82.07% | $57.77 | $105.18 | 2020-03-16 - 2021-03-17 | Buy |
C4 Therapeutics IncCCCC | +74.68% | $25.71 | $44.91 | 2020-10-26 - 2021-10-26 | Buy |
Arcellx IncACLX | +44.78% | $52.10 | $75.43 | 2023-12-18 - 2024-12-18 | Buy |
George Farmer Analyst Color
Get additional color on George Farmer's coverage of popular stocks
George Farmer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Protara Therapeutics IncTARA | 1 | Buy | $12.00 | +246.82% | Initiates Coverage On | 16 days ago |
Tempest Therapeutics IncTPST | 3 | Buy | $7.00 | +2.19% | Maintains | a month ago |
Adaptimmune Therapeutics PLCADAP | 2 | Buy | $1.40 | +409.09% | Maintains | a month ago |
Janux Therapeutics IncJANX | 4 | Hold | $41.00 | +27.93% | Maintains | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 4 | Buy | $52.00 | +159.61% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 7 | Hold | $80.00 | +27.57% | Maintains | 2 months ago |
Biogen IncBIIB | 3 | Buy | $224.00 | +85.23% | Maintains | 3 months ago |
Viking Therapeutics IncVKTX | 1 | Buy | $102.00 | +256.46% | Initiates Coverage On | 3 months ago |
Sage Therapeutics IncSAGE | 5 | Buy | $12.00 | +60.43% | Maintains | 3 months ago |
Inmune Bio IncINMB | 2 | Buy | $23.00 | +203.03% | Maintains | 3 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Hold | $16.00 | +15.77% | Maintains | 4 months ago |
Kura Oncology IncKURA | 2 | Hold | $10.00 | +54.08% | Maintains | 4 months ago |
Argenx SeARGX | 5 | Buy | $715.00 | +11.74% | Upgrades | 6 months ago |
Aura Biosciences IncAURA | 2 | Buy | $23.00 | +278.91% | Maintains | 6 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +885.22% | Initiates Coverage On | 7 months ago |
Biomea Fusion IncBMEA | 3 | Buy | $41.00 | +1,919.70% | Maintains | 7 months ago |
Legend Biotech CorpLEGN | 4 | Buy | $76.00 | +123.79% | Maintains | 9 months ago |
Absci CorpABSI | 1 | Buy | $13.00 | N/A | Initiates Coverage On | a year ago |
Arcellx IncACLX | 1 | Buy | $66.00 | N/A | Initiates Coverage On | a year ago |
Mirati Therapeutics IncMRTX | 3 | Hold | $58.00 | N/A | Upgrades | 2 years ago |
Moderna IncMRNA | 1 | Hold | $109.00 | N/A | Downgrades | 4 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $33.00 | N/A | Initiates Coverage On | 5 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Pandion Therapeutics IncPAND | 1 | Buy | $29.00 | N/A | Initiates Coverage On | 5 years ago |
Immunic IncIMUX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Seagen IncSGEN | 2 | Buy | $154.00 | N/A | Reiterates | 5 years ago |
Blueprint Medicines CorpBPMC | 2 | Buy | $89.00 | N/A | Upgrades | 5 years ago |
Exelixis IncEXEL | 1 | Hold | $20.00 | N/A | Maintains | 5 years ago |
Incyte CorpINCY | 1 | Hold | $74.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.